✦ LIBER ✦

Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia

✍ Scribed by Kantarjian, H.; Fenaux, P.; Sekeres, M. A.; Becker, P. S.; Boruchov, A.; Bowen, D.; Hellstrom-Lindberg, E.; Larson, R. A.; Lyons, R. M.; Muus, P.; Shammo, J.; Siegel, R.; Hu, K.; Franklin, J.; Berger, D. P.

Book ID: 124167694
Publisher: American Society of Clinical Oncology
Year: 2010
Tongue: English
Weight: 281 KB
Volume: 28
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2009.24.7999

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subcutaneous or intravenous administrati

Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes

✍ Mikkael A. Sekeres; Hagop Kantarjian; Pierre Fenaux; Pamela Becker; Adam Borucho 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

Long-term treatment with romiplostim in

Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy

✍ Kuter, David J.; Bussel, James B.; Newland, Adrian; Baker, Ross I.; Lyons, Roger 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB

Cause of death in patients with lower-ri

Cause of death in patients with lower-risk myelodysplastic syndrome

✍ Farshid Dayyani; Anthony P. Conley; Sara S. Strom; William Stevenson; Jorge E. C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

Efficacy and safety of deferasirox in my

Efficacy and safety of deferasirox in myelodysplastic syndromes

✍ Massimo Breccia, Giuliana Alimena 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 160 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide

✍ Eunice S Wang, Roger M Lyons, Richard A Larson, Sunil Gandhi, Delong Liu, Carmen 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 369 KB

Safety and efficacy of 5-azacytidine tre

Safety and efficacy of 5-azacytidine treatment in myelodysplastic syndrome patients with moderate and mild renal impairment

✍ Douvali, Evdoxia; Papoutselis, Menelaos; Vassilakopoulos, Theodoros P.; Papadopo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 834 KB